The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular (CV) risk markers. In this study our aim was to assess the effects of six months treatment with liraglutide 1.8 mg od on obesity, and CV risk markers, particularly platelet function, in young obese w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahal, Hassan, Aburima, Ahmed, Ungvari, Tamas, Rigby, Alan S, Coady, Anne M, Vince, Rebecca V, Ajjan, Ramzi A, Kilpatrick, Eric S, Naseem, Khalid M, Atkin, Stephen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389314/
https://www.ncbi.nlm.nih.gov/pubmed/25880805
http://dx.doi.org/10.1186/s12902-015-0005-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389314/
https://www.ncbi.nlm.nih.gov/pubmed/25880805
http://dx.doi.org/10.1186/s12902-015-0005-6

Ejemplares similares